v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Revenues $ 13,177,000 $ 6,964,000 $ 27,138,000 $ 17,932,000
Cost of sales 11,257,000 5,287,000 22,838,000 13,893,000
Gross profit 1,920,000 1,677,000 4,300,000 4,039,000
Operating expenses:        
Selling and administrative 3,904,000 3,122,000 11,402,000 9,177,000
Research and development 1,713,000 1,523,000 5,768,000 4,624,000
Total operating expenses 5,617,000 4,645,000 17,170,000 13,801,000
Operating loss (3,697,000) (2,968,000) (12,870,000) (9,762,000)
Other income (expense):        
Other income 1,307,000 1,307,000
Interest expense (52,000) (64,000) (86,000) (618,000)
Net loss $ (3,749,000) $ (1,725,000) $ (12,956,000) $ (9,073,000)
Net loss per share - basic and diluted $ (0.23) $ (0.14) $ (0.85) $ (0.80)
Weighted average number of common shares outstanding - basic and diluted 15,988,926 12,499,870 15,254,983 11,300,229

Source